Clif Bar challenges people to ride bycicles to fight global warming
LAS VEGAS Clif Bar has issued a public “2 Mile Challenge,” imploring people to leave their cars behind and instead ride bicycles for trips of less than two miles, and is taking that challenge on tour to more than 10 college campuses during October and November in a biodiesel bus with interactive exhibits, videos, commuter bicycles and accessories.
All displays are designed to showcase the benefits and ease of selecting bikes over cars for short trips to help in the fight against global warming. Clif Bar will also donate $25,000 worth of bike gear and other cycling accessories to campuses and communities to help jump start the 2 Mile Challenge among students and the general public.
“Forty percent of urban trips in the United States are two miles or less, but people use their cars nearly 90 percent of the time for those short jaunts,” stated Gary Erickson, Clif Bar co-founder. “If we simply rode bikes for those two-mile trips, we’d get in shape, unclog our roads and spare the planet from millions of tons of car-belching carbon emissions, the leading cause of global climate change.”
In addition to bike gear for campuses, Clif Bar is donating $5,000 to WorldBike, an international network of bicycle designers and industry leaders working together to provide transportation solutions and income-generating opportunities for the world’s developing countries.
The campuses include Arizona State University, Gonzaga University, Northern Arizona University, Santa Clara University, San Diego State University, University of Idaho, University of Utah, University of Oregon, University of Reno, Nevada, University of Washington, Utah State University and Washington State University.
CRN to sponsor research on healthcare professionals’ use of dietary supplements
WASHINGTON ”Life…supplemented,” an advertising campaign managed by the Council for Responsible Nutrition, on Thursday announced that it is sponsoring new research among healthcare professionals to better understand their personal use of dietary supplements and how it may impact the way they counsel their patients about dietary supplements.
“A search of the current medical literature reveals less than a dozen articles in peer-reviewed publications on the subject of personal use of supplements among clinicians, with papers published since 2000 clearly reflecting a growing interest in the topic among academicians,” stated Steve Mister, CRN’s president and chief executive officer
Mister noted, however, that because of the disparities among definitions of dietary supplements, instruments and populations surveyed, more questions are raised than are answered. “At this stage, it’s impossible to say with certainty whether the personal use of supplements by healthcare professionals correlates to their recommendations to patients.”
“This represents a significant knowledge gap that needs to be addressed,” stated Tieraona Low Dog, director of education for the University of Arizona’s Program in Integrative Medicine. “At this time, we do not know how the majority of healthcare professionals view dietary supplements in terms of their own health, or how these views then impact their discussions with patients in the clinical setting.”
Results of the survey, which will be fielded during September, are expected to be released in early November.
The online survey has been developed with Ipsos, a leading research firm.
B&L shareholders vote for merger
ROCHESTER, N.Y. Bausch & Lomb on Friday announced that its shareholders voted to approve the proposed merger with affiliates of Warburg Pincus at a special meeting of shareholders held earlier this morning.
“We are pleased with the outcome of today’s vote,” stated Ronald Zarrella, chairman and chief executive officer of Bausch & Lomb. “On behalf of the Bausch & Lomb Board and management team, I want to thank our shareholders, customers and dedicated employees for their support throughout this process. We look forward to promptly completing the transaction.”
The tabulation indicates that more than two thirds of the total shares outstanding and entitled to vote at the meeting were voted in favor of the transaction.
In accordance with the terms of the merger agreement, at the closing, each outstanding share of common and Class B stock of Bausch & Lomb will be cancelled and converted into the right to receive $65 in cash, without interest, less any applicable withholding taxes. The transaction, which is subject to customary closing conditions, is expected to close early in the third quarter. Pursuant to the merger agreement, affiliates of Warburg Pincus are not required to consummate the merger until after expiration of a “marketing period” of 20 business days following the shareholder vote. Closing of the merger is not subject to a financing condition.